ARX vs GSHD: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
ARX and GSHD are similarly sized, but ARX trades noticeably cheaper on forward earnings (12.87x vs 24.53x): the market is paying up for GSHD's profile and pricing ARX more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
ARX vs GSHD: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ARX | GSHD | What it tells you |
|---|---|---|---|
| Market cap | $2.59B | $2.37B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 12.87 | 24.53 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 13% of range | 58% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: ARX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ARX and GSHD affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARX and GSHD share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARX and GSHD exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Accelerant Holdings (ARX) do?
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. On one side are managing general agents (MGAs), the specialist underwriters who design and sell niche insurance products; on the other are risk capital partners such as insurers, reinsurers, and institutional investors who put up the capital to back those policies. Accelerant sits in the middle, using proprietary technology, data, and machine learning to match risk with capital, share high-fidelity underwriting data, and monitor portfolios. It earns a fixed-percentage, volume-based fee for sourcing, managing, and monitoring the business written through the exchange, which spans more than 500 specialty insurance products across 22 countries. The company reports through three segments: Exchange Services, MGA Operations, and Underwriting, and describes its model as capital-light because it aims to retain only a small share of the premium risk (roughly 9% in 2025) and pass the rest to third-party capital.
What does Goosehead Insurance (GSHD) do?
Goosehead Insurance, founded in 2003 in Westlake, Texas by Mark and Robyn Jones, is an independent personal-lines insurance agency. It places homeowners, auto, flood, and umbrella policies with a panel of carriers and collects a commission, so it never puts capital behind a claim. It runs two channels. The Corporate Channel employs its own agents and is the training ground and proof of concept. The Franchise Channel is the scale engine: franchisees pay an initial fee and then split commissions with Goosehead, keeping the large majority of new business commissions but only about half of renewal commissions. That split is the whole economic story, because a franchise that has been operating for several years throws off renewal royalties on a book Goosehead did not have to staff. A large share of new business arrives through referral partners, particularly real estate agents and mortgage originators at the point of home purchase.
ARX vs GSHD: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- ARX drivers: Growing the exchange network; The capital-light shift.
- GSHD drivers: Renewal royalties compounding on an aging franchise book; Producer growth, weighted toward the corporate channel.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant uncertainty is that the capital-light model is young and unproven across a full insurance cycle. For GSHD, the valuation is the first-order risk: roughly 40x trailing earnings on an ~8.8% net margin leaves the stock dependent on growth staying well above the industry rate, and small-cap distribution stocks derate quickly when it does not.
ARX or GSHD: which should you pick?
ARX vs GSHD: the full fundamentals
ARX. Figures are approximate and tied to the asOf date; verify live numbers before acting. Because Accelerant only listed in July 2025, its trading and reporting history is short, and its large statutory net loss diverges from the adjusted EBITDA it emphasizes, so the two frames tell different stories. The valuation reflects rapid revenue and EBITDA growth rather than current bottom-line profit, meaning the figures matter most as a gauge of how much future growth is already priced in.
GSHD. Figures are approximate and tied to the asOf date; verify live numbers before acting. Goosehead trades far above the US insurance industry's typical earnings multiple because the market treats it as a distribution compounder rather than a carrier, and comparisons to Progressive or Allstate on P/E are not meaningful given Goosehead takes no underwriting risk. The more informative comparison is against other insurance brokers, where Goosehead is still the premium-priced name on the basis of policy and premium growth. Note also that the Up-C structure means reported EPS reflects only the Class A economic interest, so headline market cap and headline EPS are not measuring the same denominator.
Headline figures (approximate, July 2026): ARX shows exchange written premium (fy 2025) ~$4.19 billion, up ~35% year over year, revenue (fy 2025 / q1 2026) ~$913 million FY 2025; ~$273 million in Q1 2026 (up ~54%), adjusted ebitda ~$282 million FY 2025; ~$66 million in Q1 2026 (up ~69%), net income (fy 2025) ~$1.35 billion loss, almost all from a ~$1.38 billion non-cash IPO item; GSHD shows revenue (ttm) ~$401.6 million, revenue (q2 2026) ~$113.4 million, up ~21% year over year (core revenue ~$95.6 million, up ~10%), net income (ttm) ~$35.3 million, a net margin near 8.8%, adjusted ebitda (q2 2026) ~$37.9 million, up ~30%, at a ~33% margin.
The bottom line: ARX vs GSHD
ARX and GSHD are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ARX and GSHD exposure against your real portfolio. It is not an investment adviser.
Wondering how ARX or GSHD fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Accelerant Holdings with AI
Connect the broker you already use and ask Walnut's AI how ARX fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between ARX and GSHD?
+
Accelerant Holdings operates a data-driven risk exchange for specialty insurance. Goosehead Insurance, founded in 2003 in Westlake, Texas by Mark and Robyn Jones, is an independent personal-lines insurance agency. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ARX or GSHD the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ARX or GSHD?
+
On forward P/E (as of August 2026), ARX trades at 12.87x and GSHD at 24.53x, so ARX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ARX and GSHD?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ARX vs GSHD?
+
ARX: The dominant uncertainty is that the capital-light model is young and unproven across a full insurance cycle. Accelerant still reported a large net loss in 2025, and while it was driven by a one-time non-cash IPO item, the gap between statutory results and adjusted metrics means the reported economics deserve scrutiny. As a marketplace, the business depends on keeping both MGAs and capital partners engaged; if capital providers pull back after a run of claims or if competing carriers and fronting platforms court its MGAs, volumes and fees could suffer. Specialty insurance is inherently cyclical, and a soft pricing market or a spike in catastrophe or liability losses could reduce premium flow and pressure the small share of risk Accelerant does retain. The stock is also newly public with a short trading history and a valuation that already embeds continued rapid growth, so disappointments can move it sharply. GSHD: The valuation is the first-order risk: roughly 40x trailing earnings on an ~8.8% net margin leaves the stock dependent on growth staying well above the industry rate, and small-cap distribution stocks derate quickly when it does not. The homeowners hard market is a double-edged input, because rate increases lift commissions today but carrier appetite has tightened in Texas, Florida, and California, and a softening market would slow premium growth without any operational failure. Contingent commissions, which are carrier profit-sharing payments outside core revenue, drove much of the gap between ~21% total and ~10% core revenue growth in Q2 2026 and are not reliable year to year. New business is tied to home purchase activity through referral partners, so mortgage rates and existing home sales are exogenous drivers of a company-specific line. Governance carries the usual founder-controlled features of an Up-C structure with Class A and Class B shares, and the CEO transition at year end 2026 adds execution uncertainty. Goosehead also disclosed a March 2025 network intrusion where customer notification did not go out until October, which has drawn consumer litigation.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ARX or GSHD; figures are approximate and dated (as of August 2026). Verify current data before investing.